Earth Science Tech (ETST) Long-Term Deferred Tax (2014 - 2026)
Earth Science Tech (ETST) posted Long-Term Deferred Tax of $772294.0 for Q1 2026, up 306.88% on a QoQ basis from $189807.0 in Q1 2015.
Earth Science Tech (ETST) Long-Term Deferred Tax (2014 - 2026) Analysis & Trends
Earth Science Tech's Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $772294.0 for Q1 2026.
- Quarterly Long-Term Deferred Tax changed N/A year-over-year to $772294.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $772294.0 (changed N/A YoY) and the FY2026 annual result came in at $772294.0, changed N/A from the prior year.
- Long-Term Deferred Tax was $772294.0 for Q1 2026 at Earth Science Tech, up from $189807.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $772294.0 in Q1 2026 and bottomed at $772294.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Earth Science Tech | 41.03 Mn | 38.90 Mn | 6.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 772,294.00 |
| Mar 31, 2015 | 189,807.00 |
| Mar 31, 2014 | 57,916.00 |